Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM

Fig. 4

A summary of metabolite changes (1D GC/TOFMS data) between ASS+ve and ASS-ve cells in relation to biochemical mechanisms; metabolites in the Arginine biosynthesis pathway are coloured grey. The arrows describe the concentration change for the individual metabolites where ↑ indicate a metabolite higher in concentration in ASS+ve cells (lower in ASS-ve) and ↓ indicate a metabolite lower in concentration in ASS+ve cells (higher in ASS-ve). Open arrow represents cell supernatant and grey arrow cell pellet

Back to article page